Julie Stackhouse
Medical · Roseville, CANPI 1447275268
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 127 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,170, 2.6 times the $443 reported in 2021.
Across 127 payments — averaging $29.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Electronic Waveform Lab, Inc.$805
- Boston Scientific$721
- Medtronic$394
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$352
- Painteq LLC$233
- Saluda Medical Americas, Inc.$187
- plus $1K from 16 others
What the payments were for
- Food & beverage$3,723100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Electronic Waveform Lab, Inc. | 17 | $805 |
| Boston Scientific | 16 | $721 |
| Medtronic | 17 | $394 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 21 | $352 |
| Painteq LLC | 3 | $233 |
| Saluda Medical Americas, Inc. | 3 | $187 |
| Relievant Medsystems, Inc. | 9 | $181 |
| Collegium Pharmaceutical, Inc. | 9 | $149 |
| Si-bone, Inc. | 2 | $122 |
| Scilex Pharmaceuticals Inc. | 6 | $114 |
| Almatica Pharma LLC | 6 | $108 |
| Biodelivery Sciences International, Inc. | 3 | $52 |
| SPR Therapeutics, Inc | 2 | $45 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $44 |
| Vertex | 2 | $43 |
| Redhill Biopharma Inc. | 2 | $39 |
| Abbott | 2 | $34 |
| Nalu Medical, Inc. | 1 | $28 |
| Amgen | 1 | $21 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| Averitas Pharma Inc. | 1 | $15 |
| Nevro Corp. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$248
- PAINTEQ$119
- Infinion 16$113
How this compares
$3,723 in reported general payments places this provider in the 80th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 42 | $26,512 |
| MovantikNaloxegol Oxalate | 56 | $22,337 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 389 | $10,409 |
| Buprenorphine | 15 | $4,069 |
| OxycontinOxycodone Hcl | 12 | $3,741 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 15 | $3,049 |
| Buprenorphine Hcl | 78 | $2,571 |
| Gabapentin | 179 | $2,537 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 81 | $2,061 |
| Lidocaine | 22 | $1,962 |
| Naloxone Hcl | 22 | $1,460 |
| Baclofen | 86 | $1,182 |
| Morphine Sulfate ErMorphine Sulfate | 42 | $1,125 |
| Hydroxyzine Hcl | 61 | $1,051 |
| Pregabalin | 32 | $834 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca | $149 | $26,51242 claims |
| Redhill Biopharma Inc.Movantik | $39 | $22,33756 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,087 medical providers in California.
Other medical in Roseville
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
- David DoriguzziLancaster$166K
- Deirdre MoxleyFullerton$149K
- Linda RankLadera Ranch$105K
- Cheryl KyinnSan Diego$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.